[Laboratory diagnostics of systemic autoimmune diseases. Part II: rheumatoid arthritis and vasculopathies].
This is the second part in a series of articles on the laboratory diagnostics of rheumatic diseases. It addresses rheumatoid arthritis, systemic, anti-neutrophil cytoplasmatic antibody (ANCA) positive vasculitides and antiphospholipid-syndrome. The diagnostics of rheumatoid arthritis has been substantially improved by the recently introduced assay for antibodies against citrullinated peptides. In addition, a number of vasculitides can be differentiated by the presence of ANCA. Beta2-glycoprotein I antibodies and lupus anticoagulants are at present the most specific markers for antiphospholipid syndrome. Inflammatory activity can be monitored by determining the levels of acute phase proteins and erythrocyte sedimentation rate, but only in some situations by measuring immunoglobulins and interleukins.
Hartung
K
K
Institut für Laboratoriums- und Transfusionsmedizin, Klinikum Bremerhaven Reinkenheide, Postbrookstrasse 103, 27574 Bremerhaven. Klaus.Hartung@klinikum-bremerhaven.de
Seelig
H-P
HP
D001172:Arthritis, Rheumatoid / Q000175:diagnosis*; D001327:Autoimmune Diseases / Q000175:diagnosis*; D019411:Clinical Laboratory Techniques / Q000639:trends*; D005858:Germany; D006801:Humans; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians' / Q000639:trends; D014657:Vasculitis / Q000175:diagnosis*